ATP13A2 Products

Description

Neurodegenerative disorders such as Parkinson and Alzheimer disease cause motor and cognitive dysfunction and belong to a heterogeneous group of common and disabling disorders. ATP13A2, otherwise known as PARK9, is a neuronal P-type ATPase gene underlying an autosomal recessive form of early-onset parkinsonism with pyramidal degeneration and dementia. ATP13A2 protein is located in the membrane of these lysosomes and is formed most strongly in the brain, especially in the substantia nigra, a brain region which is known to play a central role in Parkinson's disease.

Bioinformatics

Entrez	23400 Human
Uniprot	NP_071372 Human Q9NQ11 Human
Product By Gene ID	23400
Alternate Names	ATPase type 13A2 EC 3.6.3 EC 3.6.3.- EC 3.6.3.5 EC 3.6.3.8 FLJ26510 HSA9947 KRPPD PARK9putative ATPase Parkinson disease (autosomal recessive) 9 (Kufor-Rakeb syndrome) probable cation-transporting ATPase 13A2

Research Areas for ATP13A2

Find related products by research area and learn more about each of the different research areas below.

Cancer
Neurodegeneration
Neuroscience
Plasma Membrane Markers
Signal Transduction